Chris Regens is a seasoned professional in the field of chemistry, currently serving as the Director of Small Molecule Process Chemistry and Innovation. They have held various positions at Gilead Sciences from 2015 to 2018, advancing from Research Scientist I to Director. Prior to that, Chris worked as a Research Investigator II at Bristol-Myers Squibb from 2011 to 2013, contributing to the development of small molecule drug candidates. Additionally, Chris is an active member of the Board of Directors for both the Enabling Technologies Consortium and the Allotrope Foundation since 2025. Chris earned a Bachelor of Arts in Chemistry from Lake Forest College and a PhD in Chemistry from the University of Illinois at Urbana-Champaign.
This person is not in the org chart
This person is not in any teams
This person is not in any offices